Barrett’s esophagus (BE) predisposes patients to esophageal adenocarcinoma. 3 to 6% of individuals with gastro-esophageal reflux disease are estimated to have BE but only 20 to 25% of BE patients…
Despite the availability of safe and effective endoscopic treatment of Barrett’s esophagus (BE)–related dysplasia and neoplasia, the incidence and mortality from esophageal adenocarcinoma (EAC) have continued to increase. This likely…
Barrett’s esophagus and esophageal adenocarcinoma diagnoses have increased markedly in recent decades. Recent research with patients diagnosed with Barrett’s esophagus (the only known precursor for esophageal adenocarcinoma) and esophageal adenocarcinoma…
Nicholas J. Shaheen, MD, MPH, Editor I am so pleased to introduce this issue of Gastrointestinal Endoscopy Clinics of North America , “New Directions in Barrett’s Esophagus.” In terms of…
Charles J. Lightdale, MD, Consulting Editor The incidence of esophageal adenocarcinoma has risen 10-fold in the United States since the 1970s and continues to rise at an alarming rate. While…
